Skip to Content

Hysingla ER Approval History

  • FDA approved: Yes (First approved November 20th, 2014)
  • Brand name: Hysingla ER
  • Generic name: hydrocodone bitartrate
  • Dosage form: Extended-Release Tablets
  • Company: Purdue Pharma LP
  • Treatment for: Chronic Pain

Hysingla ER (hydrocodone) is a single-entity (without acetaminophen) extended-release opioid analgesic for around-the-clock management of moderate to severe chronic pain.

Development History and FDA Approval Process for Hysingla ER

Nov 20, 2014Approval FDA Approves Hysingla ER - Extended-Release Hydrocodone with Abuse-Deterrent Properties

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.